Title:
ANTIBODY AGAINST HUMAN IL-4RA AND USE THEREOF
Document Type and Number:
Japanese Patent JP2023126929
Kind Code:
A
Abstract:
To provide antibody medicaments with high affinity to human IL-4RA for treating allergic diseases with better efficacy and less severe toxic and side effects.SOLUTION: Provided herein is an antibody or an antigen-binding fragment thereof binding to IL4RA, preferably human IL4RA, where the antibody comprises HCDR1, HCDR2, and HCDR3, each consisting of a specific sequence, and furthermore, the antibody comprises LCDR1, LCDR2, and LCDR3, each consisting of a specific sequence, or the antibody is secreted by a hybridoma cell having the accession number of CCTCC NO:C202010.SELECTED DRAWING: None
More Like This:
| JP2023546743 | Anti-CD73 antibody and its use |
| JP2022020049 | ANTIGEN-BINDING COMPLEX HAVING AGONISTIC ACTIVITY AND METHOD OF USING THE SAME |
| JP2022002546 | CELL |
Inventors:
LI BAIYONG
XIA YU
WANG ZHONGMIN
JIANG PENG
XIA YU
WANG ZHONGMIN
JIANG PENG
Application Number:
JP2023111199A
Publication Date:
September 12, 2023
Filing Date:
July 06, 2023
Export Citation:
Assignee:
AKESO BIOPHARMA INC
International Classes:
C12N15/13; A61K39/395; A61K47/68; A61P11/00; A61P11/02; A61P11/06; A61P17/00; A61P35/00; A61P37/02; A61P37/08; A61P43/00; C07K16/28; C07K16/46; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N5/16; C12N15/63; C12P21/08; G01N33/53
Attorney, Agent or Firm:
Patent Attorney Corporation Tsukuni